Molecular docking revealed the binding of nucleotide/side inhibitors to Zika viral polymerase solved structures
- PMID: 29652194
- DOI: 10.1080/1062936X.2018.1454981
Molecular docking revealed the binding of nucleotide/side inhibitors to Zika viral polymerase solved structures
Abstract
A new Zika virus (ZIKV) outbreak started in 2015. According to the World Health Organization, 84 countries confirmed ZIKV infection. RNA-dependent RNA polymerase (RdRp) was an appealing target for drug designers during the last two decades. Through molecular docking, we screened 16 nucleotide/side inhibitors against ZIKV RdRp. While the mode of interaction with ZIKV is different from that in the hepatitis C virus (HCV), nucleotide/side inhibitors in this study (mostly anti-HCV) showed promising binding affinities (-6.2 to -9.7 kcal/mol calculated by AutoDock Vina) to ZIKV RdRp. Setrobuvir, YAK and, to a lesser extent, IDX-184 reveal promising results compared to other inhibitors in terms of binding ZIKV RdRp. These candidates would be powerful anti-ZIKV drugs.
Keywords: NS5 solved structure; RNA-dependent RNA polymerase; Zika virus; drug protein interaction; molecular docking.
Similar articles
-
Purification of Zika virus RNA-dependent RNA polymerase and its use to identify small-molecule Zika inhibitors.J Antimicrob Chemother. 2017 Mar 1;72(3):727-734. doi: 10.1093/jac/dkw514. J Antimicrob Chemother. 2017. PMID: 28069884 Free PMC article.
-
Zika viral polymerase inhibition using anti-HCV drugs both in market and under clinical trials.J Med Virol. 2016 Dec;88(12):2044-2051. doi: 10.1002/jmv.24678. Epub 2016 Sep 20. J Med Virol. 2016. PMID: 27604059
-
Novel guanosine derivatives against Zika virus polymerase in silico.J Med Virol. 2020 Jan;92(1):11-16. doi: 10.1002/jmv.25573. Epub 2019 Aug 29. J Med Virol. 2020. PMID: 31436327 Free PMC article.
-
Structure and function of Zika virus NS5 protein: perspectives for drug design.Cell Mol Life Sci. 2018 May;75(10):1723-1736. doi: 10.1007/s00018-018-2751-x. Epub 2018 Feb 8. Cell Mol Life Sci. 2018. PMID: 29423529 Free PMC article. Review.
-
The A-Z of Zika drug discovery.Drug Discov Today. 2018 Nov;23(11):1833-1847. doi: 10.1016/j.drudis.2018.06.014. Epub 2018 Jun 20. Drug Discov Today. 2018. PMID: 29935345 Free PMC article. Review.
Cited by
-
Identification of SARS-CoV-2 RNA-dependent RNA polymerase inhibitors from the major phytochemicals of Nigella sativa: An in silico approach.Saudi J Biol Sci. 2022 Jan;29(1):394-401. doi: 10.1016/j.sjbs.2021.09.002. Epub 2021 Sep 8. Saudi J Biol Sci. 2022. PMID: 34518755 Free PMC article.
-
Novel adenosine derivatives against SARS-CoV-2 RNA-dependent RNA polymerase: an in silico perspective.Pharmacol Rep. 2021 Dec;73(6):1754-1764. doi: 10.1007/s43440-021-00300-9. Epub 2021 Jun 24. Pharmacol Rep. 2021. PMID: 34165771 Free PMC article.
-
Structure-Based Drug Design of RdRp Inhibitors against SARS-CoV-2.Top Curr Chem (Cham). 2023 Jun 15;381(5):22. doi: 10.1007/s41061-023-00432-x. Top Curr Chem (Cham). 2023. PMID: 37318607 Review.
-
Discovering Potential RNA Dependent RNA Polymerase Inhibitors as Prospective Drugs Against COVID-19: An in silico Approach.Front Pharmacol. 2021 Feb 26;12:634047. doi: 10.3389/fphar.2021.634047. eCollection 2021. Front Pharmacol. 2021. PMID: 33716752 Free PMC article.
-
Molecular dynamics simulations and MM-GBSA reveal novel guanosine derivatives against SARS-CoV-2 RNA dependent RNA polymerase.RSC Adv. 2022 Jan 20;12(5):2741-2750. doi: 10.1039/d1ra07447d. eCollection 2022 Jan 18. RSC Adv. 2022. PMID: 35425333 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials